Marc Hennequart

Marc Hennequart

Auto-generated profile, based on publicly available information

Marc Hennequart

NARILIS Institute

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2023 in Science Advances
Verified
Journal Article
Open access
SPSteven E. Pilley
Steven E. Pilley
MHMarc Hennequart
Marc Hennequart
AVAnke Vandekeere
Anke Vandekeere
JBJulianna Blagih
Julianna Blagih
NLNathalie M. Legrave
Nathalie M. Legrave
CLChristiaan F. Labuschagne
Christiaan F. Labuschagne
Previous studies have revealed a role for proline metabolism in supporting cancer development and metastasis. In this study, we show that many cancer cells respond to loss of attachment by accumulating and secreting proline. Detached cells display reduced proliferation accompanied by a general decrease in overall protein production and de novo amino acid synthesis compared to attached cells. However, proline synthesis was maintained under detached conditions. Furthermore, while overall proline incorporation into proteins was lower in detached cells compared to other amino acids, there was an increased production of the proline-rich protein collagen. The increased excretion of proline from detached cells was also shown to be used by macrophages, an abundant and important component of the tumor microenvironment. Our study suggests that detachment induced accumulation and secretion of proline may contribute to tumor progression by supporting increased production of extracellular matrix and providing proline to surrounding stromal cells.

1 April 2026 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
MHMarc Hennequart
Marc Hennequart
LMLoic Mervant
Loic Mervant
JSJulie Stockis
Julie Stockis
JCJack Coomes
Jack Coomes
MZMartha M. Zarou
Martha M. Zarou
KVKaren H. Vousden
Karen H. Vousden
Acinar-to-ductal metaplasia (ADM) contributes to pancreatic repair after injury 1 . However, persistent ADM, combined with KRAS mutation, leads to the development of precancerous pancreatic intraepithelial neoplasia (PanIN) that can progress into pancreatic ductal adenocarcinoma (PDAC) 2 . While PDAC development is well documented, the metabolic rewiring that occurs during early events such as ADM is poorly understood. Here we show that aldehyde dehydrogenase 1 family member L2 (ALDH1L2), an NADPH-producing mitochondrial enzyme of the one-carbon pathway, limits reactive oxygen species (ROS) and formate production in pancreatic acinar cells. However, ALDH1L2 expression decreases progressively during ADM and is completely absent in pancreatic ductal cells. ALDH1L2 loss elevates ROS and promotes ADM in a model of pancreatitis and accelerates tumour progression in models of pancreatic cancer. We also show that formate increases during PDAC progression in mice and humans. Overall, our findings identify ROS as a driver of ADM and suggest that circulating formate may serve as a biomarker for PDAC progression.

26 August 2026 in Research Square
Verified
Preprint
Open access
PDF file
JBJulianna Blagih
Julianna Blagih
EGElpida Bokou Gianneli
Elpida Bokou Gianneli
STSébastien This
Sébastien This
FZFabio Zani
Fabio Zani
NONathalia Oliviera
Nathalia Oliviera
KVKaren Vousden
Karen Vousden
CD4⁺ T cells undergo extensive metabolic reprogramming during activation and differentiation, yet how metabolic enzymes coordinate metabolite utilisation with lineage commitment remains poorly understood. Here, we identify the metabolic enzyme TP53-induced glycolysis and apoptosis regulator (TIGAR) as a critical regulator of CD4⁺ T-cell fate. Although classically linked to glycolysis, TIGAR unexpectedly regulated CD4⁺ T-cell differentiation independently of these canonical functions. We found that TIGAR deficiency impaired glutamine utilisation, enhanced Th1 differentiation, and suppressed Th17 and regulatory T-cell generation in CD4⁺ T cells. Mechanistically, TIGAR deficiency upregulated aldose reductase, a key enzyme of polyol metabolism, and both pharmacological inhibition of aldose reductase and sorbitol supplementation recapitulated key aspects of the TIGAR-deficient phenotype, establishing the polyol pathway as a metabolic regulator of CD4⁺ T-cell differentiation and migration. In vivo, T cell-specific TIGAR ablation enhanced inflammatory IFNγ-producing CD4⁺ T-cell responses during Citrobacter rodentium infection and exacerbated T cell-mediated colitis. Consistent with these findings, Mendelian randomisation identified genetically predicted aldose reductase expression as a causal risk factor for inflammatory bowel disease in humans. Together, our findings uncover a TIGAR–polyol metabolic axis linking mitochondrial metabolism to CD4⁺ T-cell fate and intestinal inflammation, establishing polyol metabolism as a previously unrecognised metabolic checkpoint and potential therapeutic target in immune-mediated disease.

3 June 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
MWMaria L. White
Maria L. White
JMJulien Mortier
Julien Mortier
LGLova Granqvist
Lova Granqvist
DODeike J. Omnus
Deike J. Omnus
MLMax Louski
Max Louski
KJKristina Jonas
Kristina Jonas
Inorganic polyphosphate (polyP) is a ubiquitous molecule found across all domains of life. Although implicated in diverse cellular processes, including phosphate storage, stress responses, and pathogenicity, loss of polyP synthesis typically causes only mild growth defects. Here, we demonstrate an essential physiological role for polyP synthesis during recovery from phosphate starvation, when cells transition from phosphate-limited to phosphate-replete conditions. Using a comprehensive transposon sequencing approach in Caulobacter crescentus , we identify genes conferring a fitness advantage during starvation for carbon, nitrogen, or phosphate and during subsequent recovery. We find that ppk1 , encoding the polyphosphate kinase responsible for polyP synthesis, is specifically required for recovery from phosphate starvation but dispensable for entry into starvation, a result confirmed with a ppk1 deletion mutant. Mutations that reduce phosphate uptake via the phosphate-specific transport system suppress the requirement for ppk1 , indicating that polyP synthesis prevents toxic accumulation of intracellular inorganic phosphate (P i ) upon refeeding. Our findings further show that buffering intracellular P i through polyP synthesis is critical for maintaining ATP homeostasis. Together, these results define a central role for polyP synthesis in regulating intracellular phosphate balance and ATP homeostasis, thereby facilitating adaptation to fluctuating nutrient conditions.